Enfusion, Clearwater

Clearwater agrees to buy investment management platform Enfusion for $1.5B
Clearwater Analytics said it has entered into a definitive agreement to acquire investment management platform Enfusion for $1.5 billion.
Clearwater Analytics to Acquire Enfusion for $1.5 Billion Expanding its Investment Management Platform with Front-to-Back Capabilities
Clearwater Analytics (NYSE: CWAN) ("Clearwater") and Enfusion, Inc. (NYSE: ENFN) ("Enfusion") today announced their entry into a definitive merger agreement for Clearwater to acquire Enfusion, a leader in software-as-a-service (SaaS) solutions for the investment management and hedge fund industry.
Clearwater Analytics to acquire Enfusion in $1.5 billion deal
Clearwater Analytics has agreed to acquire investment management platform Enfusion in a $1.5 billion cash-and-stock deal, the companies said on Monday. Enfusion shareholders will receive $5.85 in cash and $5.
Clearwater acquires Enfusion in $1.5B financial software deal
Clearwater Analytics Holdings Inc. today announced plans to acquire Enfusion Inc., a fellow provider of financial software, for $1.5 billion in cash and stock.
Clearwater Analytics to acquire Enfusion for $11.25 per share in cash, stock
EST Clearwater Analytics (CWAN) to acquire Enfusion (ENFN) for $11.25 per share in cash, stockStay Ahead of the Market:Discover
Clearwater to acquire Enfusion to expand its Investment Management Platform
IBS Intelligence (IBSi) is the world’s only pure-play Financial Technology focused research, advisory, and fintech news analysis firm, with a 30-year track record and clients globally. We take pride in covering 400+ technology vendors globally – the largest by any analyst firm in this space.
Clearwater Analytics to buy Enfusion for $11.25 a share
Clearwater Analytics (NYSE:CWAN) has agreed to acquire Enfusion (NYSE:ENFN) for $11.25 a share, delivered in an approximately equal mix of cash and stock. Clearwater (NYSE:CWAN) is expected to pay a total of approximately $760M in cash and issue between approximately 23M and 28M new shares to Enfusion (NYSE:ENFN) shareholders.
Clearwater To Acquire Enfusion - Quick Facts
Clearwater Analytics (CWAN) and Enfusion (ENFN) announced a definitive merger agreement for Clearwater to acquire Enfusion. Enfusion
KBOI Boise on MSN4h
Clearwater Analytics founder in Boise appointed by Trump to Dept. of Agriculture
Michael Boren, the founder of Clearwater Analytics in Boise, has been appointed by incoming President Trump to a posting ...
Clearwater Analytics to buy software maker Enfusion for $1.5 billion to drive global expansion
Clearwater Analytics has agreed to acquire Enfusion in a $1.5 billion cash-and-stock deal as the financial software maker ...
Clearwater Analytics upgraded to Buy from Neutral at DA Davidson
DA Davidson analyst Peter Heckmann upgraded Clearwater Analytics (CWAN) to Buy from Neutral with a $32 price target Stay Ahead of the ...
Reuters4d
Clearwater to buy software maker Enfusion for $1.5 bln in expansion push
Jan 13 (Reuters) - Clearwater Analytics (CWAN.N), opens new tab has agreed to acquire Enfusion (ENFN.N), opens new tab in a $1.5 billion cash-and-stock deal as the financial software maker looks ...
Traders Magazine3d
Clearwater Analytics to Acquire Enfusion for $1.5 Billion
BOISE, Idaho and CHICAGO, Illinois – January 13, 2025 – Clearwater Analytics (NYSE: CWAN) (“Clearwater”) and Enfusion, Inc. (NYSE: ENFN) (“Enfusion”) today announced their entry into a definitive ...
Yahoo Finance3d
Clearwater to buy software maker Enfusion for $1.5 billion in expansion push
By Arasu Kannagi Basil and Niket Nishant (Reuters) -Clearwater Analytics has agreed to acquire Enfusion in a $1.5 billion cash-and-stock deal as the financial software maker looks to bolster its ...
Clearwater Analytics price target lowered to $30 from $36 at RBC Capital
RBC Capital lowered the firm’s price target on Clearwater Analytics (CWAN) to $30 from $36 but keeps an Outperform rating on the shares after ...
bovnews2d
What’s Fueling Clearwater Analytics Holdings Inc (CWAN) Stock’s 12.21% Gain Above Its 200-Day SMA?
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 22.42% ...